Friday, June 26, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 786 of 1,261
  1. US 8865745

    Pyrazolone derivatives as PDE4 inhibitors

    TAKEDA GMBH · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  2. US 8865741

    Aminoindane compounds and use thereof in treating pain

    Asana BioSciences, LLC · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  3. US 8865187

    Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity

    The Board of Regents of the University of Texas System · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  4. US 8865461

    Rabies virus vector systems and compositions and methods thereof

    The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  5. US 8865230

    Compositions and methods for treating parasitic infections

    TYRATECH, INC. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  6. US 8865748

    Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer

    Akebia Therapeutics, Inc. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  7. US 8865723

    Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury

    Tetra Discovery Partners · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  8. US 8865728

    Combinations comprising methotrexate and DHODH inhibitors

    Almirall, S.A. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  9. US 8865722

    Wet formulations of aripiprazole

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  10. US 8865694

    Topical compositions for treatment of skin conditions

    Molecular Design International, Inc. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  11. US 8865719

    Substituted heterocycles and their use as allosteric modulators of nicotinic and GABAA receptors

    The Regents of the University of California · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  12. US 8865469

    Methods of transforming a Listeria

    The Regents of the University of California · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  13. US 8865672

    Prevention of tissue ischemia and related methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  14. US 8865210

    Stable dosage formulations of imidazolylalkyl-pyridines

    VANDA PHARMACEUTICALS INC. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  15. US 8865217

    Oral preparation comprising pioglitazone

    Takeda Pharmaceutical Company Limited · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  16. US 8865430

    Fusion polypeptides capable of activating receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  17. US 8865199

    Biomatrix composition and methods of biomatrix seeding

    The Board of Regents of the University of Texas System · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  18. US 8865175

    Increasing anti-IL-1α antibodies in a subject

    XBIOTECH INC. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  19. US 8865149

    Polymeric reagents comprising a ketone or a related functional group

    Nektar Therapeutics · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  20. US 8859750

    RNAi modulation of RSV and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  21. US 8859727

    Bioactive FUS1 peptides and nanoparticle-polypeptide complexes

    The Board of Regents of the University of Texas System · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  22. US 8859774

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  23. US 8859619

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  24. US 8859527

    Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treatment of cancer thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.